Perspective Therapeutics
CATX
49 hedge funds and large institutions have $10M invested in Perspective Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 4 closing their positions.
115% more capital inflows, than outflows
Capital inflows: $2.71M | Capital outflows: $1.26M
1.24% more ownership
Funds ownership: 11.77% → 13.01% (+1.2%)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
2% less funds holding
Funds holding: 50 → 49 (-1)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$2.48M |
| 2 |
Jane Street
New York
|
+$62.8K |
| 3 |
HRT Financial
New York
|
+$47.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$31.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Portland Investment Counsel
Burlington,
Ontario, Canada
|
-$683K |
| 2 |
BlackRock
New York
|
-$373K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$111K |
| 4 |
Renaissance Technologies
New York
|
-$32.3K |
| 5 |
Cerity Partners
New York
|
-$26.7K |
CATX Hedge Fund Activity: Q3 2023 in Review
49 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q3 2023, worth a combined $10M — down 55% from $22M a quarter earlier.
Fund positioning in CATX was balanced in Q3 2023: 4 funds opened new positions, 4 closed out, 10 added to existing stakes and 12 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $2.48M. The largest seller was Portland Investment Counsel, exiting entirely with an estimated $683K sold.
- 49 institutional investors held Perspective Therapeutics (CATX) as of Q3 2023, down from 50 in Q2 2023.
- Funds reported $10M of Perspective Therapeutics stock for Q3 2023, down 55% quarter-over-quarter.
- 4 funds opened new Perspective Therapeutics positions in Q3 2023 and 4 closed out, a net change of 0 holders.
- The largest Perspective Therapeutics buyer in Q3 2023 was Baker Bros. Advisors, an estimated $2.48M added.
- The largest Perspective Therapeutics seller in Q3 2023 was Portland Investment Counsel, an estimated $683K sold.
Based on aggregated 13F filings for Q3 2023.